On Wednesday, a panel comprised of health experts voted overwhelmingly for the U.S. Food and Drug Administration (FDA) to restrict the marketing of low-testosterone drugs, an industry currently enjoying a multibillion-dollar sales boom.
Only one member of the 20-person panel voted against changing the labeling of testosterone drugs to dissuade their use in male patients who may not have actual symptoms of low T. Many of these men are influenced by the perceived benefits as described in television commercials and advertisements: Improved sex drive, weight loss, increased muscle mass and more.
The panel expressed concern over the availability of these drugs, the use of which has quadrupled over the past decade. The indications for treating a true testosterone deficiency are very different from the reasons many men have decided to ask their doctor about such treatments. Doctors have been prescribing low-T medications for symptoms of aging, like low libido and energy loss, which are not necessarily an indication of low testosterone.
The FDA panel explained that the goal is to change the labeling and more strictly regulate the marketing of these drugs to avoid prescriptions that may be uncalled for. One of the biggest motivating factors for recently increased usage may be testosterone gels, which boast easy application and no need to take a pill. The FDA will consider whether to produce an oral alternative.
In the past, the FDA has admitted that the benefits of testosterone therapy to healthy men are less than clear, and that the medications are risky. While a label change might offer some influence, doctors may still prescribe the drugs as they see fit.
In a market mired with misleading benefits and little oversight, testosterone therapy has exploded into the multi-billion dollar industry it is today. Unfortunately, adverse events have been associated with the use of these drugs, and until now there has been no true regulation by the FDA.
The Eichholz Law Firm’s legal team believes in holding manufacturers accountable for the products they produce and market. If you or someone you love has suffered from the side effects of a low T drug, you could be entitled to compensation.